期刊
MOLECULAR BIOLOGY REPORTS
卷 48, 期 3, 页码 2601-2610出版社
SPRINGER
DOI: 10.1007/s11033-021-06312-1
关键词
Amyotrophic lateral sclerosis; TREM2; Genetic variant; Genetics; rs75932628
资金
- Research Committee of the University of Thessaly, Greece [5287]
Studies on the role of the TREM2 rs75932628 variant in ALS have shown inconsistent results. However, meta-analyses combining data from various studies did not find a significant association between the rs75932628 variant and ALS risk. This suggests that TREM2 rs75932628 may not play a determining role in the pathophysiology of ALS.
Amyotrophic lateral sclerosis (ALS) is a multifactorial neurodegenerative disease. Inflammatory processes are among the mechanisms that are implicated in ALS pathogenesis. The TREM2 rs75932628 T variant may influence the regulatory effect of TREM2 on inflammation. Studies regarding the role of the rs75932628 variant in ALS have yielded inconsistent results, so far. To assess the role of TREM2 rs75932628 on ALS risk. We genotyped 155 patients with sporadic ALS and 155 healthy controls for TREM2 rs75932628. We also merged and meta-analyzed our data with data from previous studies (with a total of 7524 ALS cases and 14,675 controls), regarding TREM2 rs75932628 and ALS. No ALS or healthy subjects carried the TREM2 rs75932628-T variant. Results from meta-analyses (overall approach and sensitivity analyses) yielded no significant results for possible connection between TREM2 rs75932628-T variant and ALS. Based on our results, TREM2 rs75932628 does not seem to play a determining role to the pathophysiology of ALS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据